378 related articles for article (PubMed ID: 34895759)
21. [Hormone therapy, cardio-metabolic profile, and cardiotoxicity. Still a dark side of cardio-oncology - Part 2: Prostate cancer].
Tarantini L; Di Girolamo S; Masini C; Cioffi G; Foglietta J; Bracarda S; Pinto C; Navazio A
G Ital Cardiol (Rome); 2023 Oct; 24(10):781-791. PubMed ID: 37767830
[TBL] [Abstract][Full Text] [Related]
22. Optimizing cardio-oncology programs for cancer patients.
Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
[No Abstract] [Full Text] [Related]
23. Cardiotoxicity: anthracyclines and long term cancer survivors.
Patanè S
Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
[No Abstract] [Full Text] [Related]
24. Cardio-oncology: the new frontier of clinical and preventive cardiology.
Paris S; Tarantini L; Navazio A; Faggiano P
Monaldi Arch Chest Dis; 2020 Jun; 90(2):. PubMed ID: 32571000
[TBL] [Abstract][Full Text] [Related]
25. European Society of Cardiology Core Curriculum for cardio-oncology.
López-Fernández T; Farmakis D; Ameri P; Asteggiano R; de Azambuja E; Aznar M; Barac A; Bayes-Genis A; Bax JJ; Bergler-Klein J; Boriani G; Celutkiene J; Coats A; Cohen-Solal A; Córdoba R; Cosyns B; Filippatos G; Fox K; Gulati G; Inciardi RM; Lee G; Mamas MA; Novo G; Plummer C; Psyrri A; Rakisheva A; Suter T; Tini G; Tocchetti CG; Toutouzas K; Wilhelm M; Metra M; Lyon AR; Rosano GMC
Eur J Heart Fail; 2024 Apr; 26(4):754-771. PubMed ID: 38059343
[TBL] [Abstract][Full Text] [Related]
26. Health benefits of spices in individuals with chemotherapeutic drug-induced cardiotoxicity.
Liu J; Zhang Q; Tao T; Wang LY; Sun JY; Wu CJ; Zou WJ
Curr Opin Pharmacol; 2022 Apr; 63():102187. PubMed ID: 35245798
[TBL] [Abstract][Full Text] [Related]
27. The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters".
Abe J; Martin JF; Yeh ET
Circ Res; 2016 Sep; 119(8):896-9. PubMed ID: 27688305
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines.
Alexandre J; Cautela J; Ederhy S; Damaj GL; Salem JE; Barlesi F; Farnault L; Charbonnier A; Mirabel M; Champiat S; Cohen-Solal A; Cohen A; Dolladille C; Thuny F
J Am Heart Assoc; 2020 Sep; 9(18):e018403. PubMed ID: 32893704
[TBL] [Abstract][Full Text] [Related]
29. Cardio-oncology: an ongoing evolution.
Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
[TBL] [Abstract][Full Text] [Related]
30. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.
Kersting D; Settelmeier S; Mavroeidi IA; Herrmann K; Seifert R; Rischpler C
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409161
[TBL] [Abstract][Full Text] [Related]
31. Cardio-Oncology in Childhood: State of the Art.
Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
[TBL] [Abstract][Full Text] [Related]
32. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
Romann SW; Frey N; Lehmann L
Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
[TBL] [Abstract][Full Text] [Related]
33. Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies.
Bychowski J; Sobiczewski W
Cancer Med; 2023 Jul; 12(13):14545-14555. PubMed ID: 37102247
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.
Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D
Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419
[TBL] [Abstract][Full Text] [Related]
35. Onco-cardiology: Present and future.
Sueta D; Hokimoto S
Int J Cardiol; 2016 Jul; 215():38-40. PubMed ID: 27107544
[TBL] [Abstract][Full Text] [Related]
36. [Cancer, onco-haematological treatment and cardiovascular toxicity].
Mena Sebastiá E; Tirapu Sola L; Villanueva Vázquez R; Losa Gaspà F; Freixa-Pamias R
Hipertens Riesgo Vasc; 2021; 38(2):72-82. PubMed ID: 32978077
[TBL] [Abstract][Full Text] [Related]
37. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
Lenneman CG; Sawyer DB
Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
[TBL] [Abstract][Full Text] [Related]
38. [2022 ESC guidelines on cardio-oncology : Understanding and treating cardiovascular side effects from cancer therapy].
Michel L; Totzeck M; Rassaf T
Herz; 2023 Feb; 48(1):15-22. PubMed ID: 36441175
[TBL] [Abstract][Full Text] [Related]
39. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Parent S; Pituskin E; Paterson DI
Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
[TBL] [Abstract][Full Text] [Related]
40. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
